Gollob Jared 的 Form 4 申報
Kymera Therapeutics, Inc.（KYMR），2021/11/2 申報
- 申報編號
- 0000899243-21-042437
- 申報時間
- 2021/11/2
- 交易日
- 2021/11/1-11/2
- 申報延遲
- 1 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 10 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $357.4 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gollob JaredCIK 0001821198 | 高階主管（醫療長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/1 | Common Stock | M行使選擇權取得 | +20,000 | $1.31 | +$26,200 | 62,547 | 直接 | |
| 2021/11/1 | Common Stock | M行使選擇權取得 | +4,607 | $2.08 | +$9,582.56 | 67,154 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −7,387 | $60.40F2 | −$446,174.8 | 59,767 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −15,134 | $61.50F3 | −$930,741 | 44,633 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −15,911 | $62.34F4 | −$991,891.74 | 28,722 | 直接 | |
| 2021/11/1 | Common Stock | S賣出處分 | −4,065 | $63.17F5 | −$256,786.05 | 24,657 | 直接 | |
| 2021/11/2 | Common Stock | M行使選擇權取得 | +14,996 | $2.08 | +$31,191.68 | 39,653 | 直接 | |
| 2021/11/2 | Common Stock | S賣出處分 | −8,514 | $62.89F6 | −$535,445.46 | 31,139 | 直接 | |
| 2021/11/2 | Common Stock | S賣出處分 | −5,280 | $63.50F7 | −$335,280 | 25,859 | 直接 | |
| 2021/11/2 | Common Stock | S賣出處分 | −1,202 | $64.34F8 | −$77,336.68 | 24,657 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/1 | Common Stock | M行使選擇權處分 | −20,000 | $0.00 | $0 | 40,007 | 直接 | |
| 2021/11/1 | Common Stock | M行使選擇權處分 | −4,607 | $0.00 | $0 | 133,808 | 直接 | |
| 2021/11/2 | Common Stock | M行使選擇權處分 | −14,996 | $0.00 | $0 | 118,812 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.01 to $62.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.03 to $63.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.03 to $63.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.13 to $63.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.13 to $64.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.13 to $64.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。